Does LEUPROLIDE Cause Atrophy? 5 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Atrophy have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.0% of all adverse event reports for LEUPROLIDE.
5
Reports of Atrophy with LEUPROLIDE
0.0%
of all LEUPROLIDE reports
1
Deaths
1
Hospitalizations
How Dangerous Is Atrophy From LEUPROLIDE?
Of the 5 reports, 1 (20.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Atrophy Listed in the Official Label?
Yes, Atrophy is listed as a known adverse reaction in the official FDA drug label for LEUPROLIDE.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Atrophy?
ADALIMUMAB (76)
ETANERCEPT (43)
METHOTREXATE (37)
TRIAMCINOLONE ACETONIDE (36)
METHYLPREDNISOLONE (34)
INTERFERON BETA-1A (33)
ALENDRONATE (32)
SECUKINUMAB (30)
RITUXIMAB (29)
FINGOLIMOD (28)
Which LEUPROLIDE Alternatives Have Lower Atrophy Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM